Retrouvez-nous désormais sur https://phi-advisor.com/fr/
pour bénéficier de nos signaux d’achat et de vente de plus de 300 ETFs !
My Weblog:
Ümraniye elektrikçi
üsküdar elektrikci
usta elektrikci
sisli elektrikci
https://www.enigma-furnishings.co.uk/?p=584
https://alhajjabulkashemhosnearastudentconsultancy.com/?p=16620
https://asociacionderecicladoresdelmeta.org/?p=17407
https://contractorresults.com/?p=357
https://gabon-environnement.com/?p=3703
https://igyoushu.biz/?p=248
https://immd.kiev.ua/?p=5735
https://kimnammarine.com/?p=1366
https://kinglouis.fr/?p=3167
https://shemirancenter.com//?p=5652
https://smartaxconsultancy.co.uk/?p=929
https://tsamadopaco.fr/?p=4222
https://tvnasalsinus.com/?p=2111
https://yypark.net/?p=135
We include in our watchlist the ETF SPDR XPH which replicates the S&P 500 Pharmaceutical Index, and is composed mainly of 41 specialty pharmaceutical stocks. This ETF expenses reach 0.35% with a liquidity of $44m and appears to be an attractive short-term trading opportunity. The long-term chart seems ready for a change in trend, which is reflected in a bullish crossover of the MACD as the prices approach the EMA26. A breakout of the 44/45 $ zone would be a significant positive factor.
XPH : monthly data
The weekly chart is improving strongly, through the ascending moving averages and the bullish MACD. It remains an important step to cross : the M100 located at 44.3 $.
Once this area is crossed, the trend would clearly become bullish.
XPH : weekly data